Evidence map›Paper›PMID 28191776›Full record

ArticleStem cells translational medicine2017

Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.

Daniëlle G Leuning, Marlies E J Reinders, Joan Li, Anna J Peired, Ellen Lievers, Hetty C de Boer, Willem E Fibbe, Paola Romagnani, Cees van Kooten, Melissa H Little and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Stem cells translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Stem Cell Therapies in Kidney Diseases: Progress and Challenges.International journal of molecular sciences · 2019
    Review
  15. Mesenchymal Stem Cells-Potential Applications in Kidney Diseases.International journal of molecular sciences · 2019
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Daniëlle G LeuningDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Marlies E J ReindersDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Joan LiInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
Anna J PeiredExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies, University of Florence, Florence, Italy.
Ellen LieversDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Hetty C de BoerDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Willem E FibbeDepartment of Immunology and Hematology, Leiden University Medical Centre, Leiden, The Netherlands.
Paola RomagnaniExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies, University of Florence, Florence, Italy.
Cees van KootenDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Melissa H LittleInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
Marten A EngelseDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Ton J RabelinkDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Leiden University · NLLeiden University Medical Center · NLUniversity of Florence · ITUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stromal cells (MSCs) are immunomodulatory and tissue homeostatic cells that have shown beneficial effects in kidney diseases and transplantation. Perivascular stromal cells (PSCs) identified within several different organs share characteristics of bone marrow-derived MSCs (BM-MSCs). These PSCs may also possess tissue-specific properties and play a role in local tissue homeostasis. We hypothesized that human kidney-derived PSCs (hkPSCs) would elicit improved kidney repair in comparison with BM-MSCs. Here we introduce a novel, clinical-grade isolation method of hkPSCs from cadaveric kidneys by enriching for the perivascular marker, NG2. hkPSCs show strong transcriptional similarities to BM-MSCs but also show organotypic expression signatures, including the HoxD10 and HoxD11 nephrogenic transcription factors. Comparable to BM-MSCs, hkPSCs showed immunosuppressive potential and, when cocultured with endothelial cells, vascular plexus formation was supported, which was specifically in the hkPSCs accompanied by an increased NG2 expression. hkPSCs did not undergo myofibroblast transformation after exposure to transforming growth factor-β, further corroborating their potential regulatory role in tissue homeostasis. This was further supported by the observation that hkPSCs induced accelerated repair in a tubular epithelial wound scratch assay, which was mediated through hepatocyte growth factor release. In vivo, in a neonatal kidney injection model, hkPSCs reintegrated and survived in the interstitial compartment, whereas BM-MSCs did not show this potential. Moreover, hkPSCs gave protection against the development of acute kidney injury in vivo in a model of rhabdomyolysis-mediated nephrotoxicity. Overall, this suggests a superior therapeutic potential for the use of hkPSCs and their secretome in the treatment of kidney diseases. Stem Cells Translational Medicine 2017;6:405-418.

Indexed as

RegenerationAnimalsAntigensBiomarkersCell DifferentiationCell LineageCell MovementCell ProliferationCells, CulturedCell SeparationChondroitin Sulfate Proteoglycan 4Coculture TechniquesDisease Models, AnimalGenotypeHomeodomain ProteinsHumansAntigensBiomarkersChondroitin Sulfate Proteoglycan 4Homeodomain ProteinsHOXD10 protein, humanHOXD11 protein, humanProteoglycansTranscription FactorsCellular therapyClinical translationKidneyMesenchymal stromal cellsPericytesStromal cellsTissue regenerationTissue-specific stem cells

Identifiers

PMID28191776
PMCPMC5442810
OpenAlexW2521087205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.